NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / At least half of Indians have COVID-19 antibodies: Credit Suisse
    India

    At least half of Indians have COVID-19 antibodies: Credit Suisse

    At least half of Indians have COVID-19 antibodies: Credit Suisse
    Written by Ramya Patelkhana
    Jun 09, 2021, 11:03 pm 3 min read
    At least half of Indians have COVID-19 antibodies: Credit Suisse
    Credits

    Leading financial services company Credit Suisse revealed at least half of the Indian population, as per its estimates, would now have developed antibodies against COVID-19 caused by the novel coronavirus. Neelkanth Mishra, Co-head of Asia Pacific Strategy and India Equity Strategist, Credit Suisse, said many Indian districts would have moved beyond the herd immunity phase even for the highly infectious Delta variant. Here's more.

    About 77 crore Indians would have already developed COVID-19 antibodies

    Speaking to The Print, Mishra said as per Credit Suisse's estimates about 77 crore people in India would have already developed COVID-19 antibodies—a little more than half of India's population. This high seroprevalence of COVID-19 antibodies and the ongoing relaxation of lockdown and other restrictions across many states may even lead to a "steep rebound" of the gross domestic product (GDP) in the country.

    Estimates based on hypotheses; national seroprevalence survey recommended: Mishra

    Moreover, Mishra said these estimates are based only on hypotheses and not the real-time status. "We recommend a granular and nationwide seroprevalence study," he said. Credit Suisse's estimates are based on the Indian Council of Medical Research's third serological survey that showed by mid-December 2020, 21.4% of Indians were infected and the infection-to-case ratio was 28x—one crore cases and 28 crore people with antibodies.

    Positive test ratios higher in second wave

    Mishra noted there were higher positive test ratios in the second COVID-19 wave compared to the first wave and hence ratio of those with antibodies in this wave would at least be the same as the first wave and "possibly even higher."

    Mishra explains how 77 crore Indians would have developed antibodies

    Estimating the number of people with antibodies, Mishra said, "If, to be conservative, one model with 20x, we are at about 60 crore infections (28 crore in the first wave and 32 crore in the second wave) in addition to 17 crore people with at least one jab of the vaccine." So, about 77 crore people in the country would now have developed antibodies.

    It's estimated many districts would be well beyond herd immunity

    Mishra said, "From this (estimated 77 crore with antibodies) you take out say 5 crore for double-counting—such as people infected twice or thrice or overlaps between those with infections and those with vaccination—and you still have around half the population with antibodies." "If you use 30x, many districts would be well beyond herd immunity even for the much more infectious Delta variant," he added.

    A steep rebound of GDP in India likely: Mishra

    Mishra also spoke about the GDP, saying it should witness a significant improvement as lockdown restrictions are being lifted gradually—the rebound would be "steep." "If active cases continue to fall...steeply...relaxation of lockdowns is likely to be faster. While we need to be on the lookout for another surge...as activities resume, the likely high seroprevalence should reduce the risk of that occurrence," he said.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Coronavirus
    COVID-19
    Coronavirus Cases In India

    Coronavirus

    Free vaccines; on-site registration: Centre revises COVID-19 vaccination policy Narendra Modi
    Coronavirus: India reports under 1 lakh cases after 63 days Ministry of Health and Family Welfare
    Gangrene, hearing loss suggest Delta variant more severe, say doctors India
    Delhi to vaccinate 45 plus age group at polling booths Arvind Kejriwal

    COVID-19

    India must increase vaccinations five-fold to reach 100% target: Report India
    Amitabh Bachchan to resume work as Maharashtra relaxes COVID-19 rules Mumbai
    No work, haven't paid half of last year's tax: Kangana Narendra Modi
    Priyanka Gandhi slams Yogi government over Agra hospital's 'mock drill' Agra

    Coronavirus Cases In India

    India is among beneficiaries receiving 25 million vaccines from US Vaccine
    Don't fall for rumors claiming alcohol protects against coronavirus: Expert Punjab
    COVID-19: Supreme Court advises Centre, states to impose lockdown Supreme Court Of India
    COVID-19 crisis: Six Bollywood celebrities who are doing their bit India

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023